Literature DB >> 11160138

Ornithine decarboxylase, kidney size, and the tubular hypothesis of glomerular hyperfiltration in experimental diabetes.

S C Thomson1, A Deng, D Bao, J Satriano, R C Blantz, V Vallon.   

Abstract

In early diabetes, the kidney grows and the glomerular filtration rate (GFR) increases. This growth is linked to ornithine decarboxylase (ODC). The study of hyperfiltration has focused on microvascular abnormalities, but hyperfiltration may actually result from a prior increase in capacity for proximal reabsorption which reduces the signal for tubuloglomerular feedback (TGF). Experiments were performed in Wistar rats after 1 week of streptozotocin diabetes. Kidney weight, ODC activity, and GFR were correlated in diabetic and control rats given difluoromethylornithine (DFMO; Marion Merrell Dow, Cincinnati, Ohio, USA) to inhibit ODC. We assessed proximal reabsorption by micropuncture, using TGF as a tool for manipulating single-nephron GFR (SNGFR), then plotting proximal reabsorption versus SNGFR. ODC activity was elevated 15-fold in diabetic kidneys and normalized by DFMO, which also attenuated hyperfiltration and hypertrophy. Micropuncture data revealed an overall increase in proximal reabsorption in diabetic rats too great to be accounted for by glomerulotubular balance. DFMO prevented the overall increase in proximal reabsorption. These data confirm that ODC is required for the full effect of diabetes on kidney size and proximal reabsorption in early streptozotocin diabetes and are consistent with the hypothesis that diabetic hyperfiltration results from normal physiologic actions of TGF operating in a larger kidney, independent of any primary malfunction of the glomerular microvasculature.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11160138      PMCID: PMC199175          DOI: 10.1172/JCI10963

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  22 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Tubuloglomerular feedback kinetics in spontaneously hypertensive and Wistar-Kyoto rats.

Authors:  F H Daniels; W J Arendshorst
Journal:  Am J Physiol       Date:  1990-09

3.  Mechanism of NaCl and water reabsorption in the proximal convoluted tubule of rat kidney.

Authors:  K H Neumann; F C Rector
Journal:  J Clin Invest       Date:  1976-11       Impact factor: 14.808

4.  Increased kidney size and glomerular filtration rate in early juvenile diabetes.

Authors:  C E Mogensen; M J Andersen
Journal:  Diabetes       Date:  1973-09       Impact factor: 9.461

5.  Effect of streptozotocin-induced diabetes on kidney weight and compensatory hypertrophy in the rat.

Authors:  J Ross; J K Goldman
Journal:  Endocrinology       Date:  1971-04       Impact factor: 4.736

Review 6.  Polyamines.

Authors:  C W Tabor; H Tabor
Journal:  Annu Rev Biochem       Date:  1984       Impact factor: 23.643

7.  Temporal adjustment of the juxtaglomerular apparatus during sustained inhibition of proximal reabsorption.

Authors:  S C Thomson; S Bachmann; M Bostanjoglo; C A Ecelbarger; O W Peterson; D Schwartz; D Bao; R C Blantz
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

8.  Renal enlargement precedes renal hyperfiltration in early experimental diabetes in rats.

Authors:  Martin Bak; Klaus Thomsen; Thora Christiansen; Allan Flyvbjerg
Journal:  J Am Soc Nephrol       Date:  2000-07       Impact factor: 10.121

Review 9.  Polyamine metabolism and function.

Authors:  A E Pegg; P P McCann
Journal:  Am J Physiol       Date:  1982-11

10.  Renal hypertrophy in streptozotocin-diabetic rats.

Authors:  K Seyer-Hansen
Journal:  Clin Sci Mol Med       Date:  1976-12
View more
  86 in total

1.  Hypertrophy and hyperfunction of the diabetic kidney.

Authors:  T H Hostetter
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

Review 2.  Sodium-glucose transport: role in diabetes mellitus and potential clinical implications.

Authors:  Volker Vallon; Kumar Sharma
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-09       Impact factor: 2.894

Review 3.  Pathogenesis of diabetic nephropathy.

Authors:  Claudia van Dijk; Tomas Berl
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

Review 4.  The clinical significance of hyperfiltration in diabetes.

Authors:  G Jerums; E Premaratne; S Panagiotopoulos; R J MacIsaac
Journal:  Diabetologia       Date:  2010-05-23       Impact factor: 10.122

5.  Transition of kidney tubule cells to a senescent phenotype in early experimental diabetes.

Authors:  Joseph Satriano; Hadi Mansoury; Aihua Deng; Kumar Sharma; Volker Vallon; Roland C Blantz; Scott C Thomson
Journal:  Am J Physiol Cell Physiol       Date:  2010-05-26       Impact factor: 4.249

6.  Agmatine induced NO dependent rat mesenteric artery relaxation and its impairment in salt-sensitive hypertension.

Authors:  Tushar V Gadkari; Natalie Cortes; Kumpal Madrasi; Nikolaos M Tsoukias; Mahesh S Joshi
Journal:  Nitric Oxide       Date:  2013-08-29       Impact factor: 4.427

Review 7.  Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors.

Authors:  Ralph A DeFronzo; W Brian Reeves; Alaa S Awad
Journal:  Nat Rev Nephrol       Date:  2021-02-05       Impact factor: 28.314

Review 8.  Hyperfiltration, nitric oxide, and diabetic nephropathy.

Authors:  David Z Levine
Journal:  Curr Hypertens Rep       Date:  2006-05       Impact factor: 5.369

Review 9.  The salt paradox and its possible implications in managing hypertensive diabetic patients.

Authors:  Volker Vallon; Roland Blantz; Scott Thomson
Journal:  Curr Hypertens Rep       Date:  2005-04       Impact factor: 5.369

10.  Ornithine decarboxylase inhibitor eliminates hyperresponsiveness of the early diabetic proximal tubule to dietary salt.

Authors:  Cynthia M Miracle; Timo Rieg; Hadi Mansoury; Volker Vallon; Scott C Thomson
Journal:  Am J Physiol Renal Physiol       Date:  2008-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.